TIV

(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione

Find entries where: TIV

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
Formula	C₂₃ H₁₉ N₃ O₂
Molecular Weight	369.416
Type	NON-POLYMER
Isomeric SMILES	c1ccc2c(c1)c(c[nH]2)[C@H]3[C@@H](C(=O)NC3=O)c4cn5c6c4cccc6CCC5
InChI	InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1
InChIKey	UCEQXRCJXIVODC-PMACEKPBSA-N

Chemical Details
Formal Charge	0
Atom Count	47
Chiral Atom Count	2
Bond Count	52
Aromatic Bond Count	20

Drug Info: DrugBank

DrugBank ID	DB12200
Name	Tivantinib
Groups	investigational
Description	Tivantinib has been investigated in Solid Tumors.
Synonyms	Tivantinib
Categories	Heterocyclic Compounds, Fused-Ring Proto-Oncogene Proteins c-met, antagonists & inhibitors Pyrrolidines
CAS number	905854-02-6

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Hepatocyte growth factor receptor	MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAET...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682